medigraphic.com

2020, Number 2

<< Back Next >>

Rev Hematol Mex 2020; 21 (2)

Solitary bone plasmocytoma in thoracic wall: a unusual presentation and a time bomb

Montoya-Castillo M

Language: Spanish
References: 21
Page: 115-119
PDF size: 243.95 Kb.


ABSTRACT

Background: Solitary plasmacytoma of the bone is a disease with low frequency, especially with involve of the rib. It is characterized by one or two bone lesions without disseminated disease and it has association with multiple myeloma. Because of this, on suspicion of solitary bone plasmacytoma, this last disease has to be discarded, in order to improve the patient’s prognosis.
Clinical case: A 53-year-old male patient, with a history of inactive smoking, who went to the emergency department with a clinical picture of three months of evolution consisting of pain with pleuritic characteristics in the left hemithorax, concomitant with wet cough, feeling of dyspnea, asthenia, adynamia and subjective weight loss, in whom solitary plasmacytoma of the bone was diagnosed and, despite receiving adequate initial treatment, suffered multiple myeloma in a matter of months.
Conclusions: Despite of an adequate management, treatment fails have been described, such as multiple myeloma progress, lesion recurrence or development of new lesions without multiple myeloma.


REFERENCES

  1. The discovery of plasma cells: An historical note. Immunol Lett 2017;188:64-67. doi:10.1016/J.IMLET.2017.06.006.

  2. Dimopoulos MA, Kiamouris C, Moulopoulos LA. Solitary plasmacytoma of bone and extramedullary plasmacytoma. Hematol Oncol Clin North Am 1999. doi:10.1016/S0889- 8588(05)70124-6.

  3. Zhang D, Cao D, Shen D, Mulmi Shrestha S, Yin Y. Extramedullary plasmacytoma occuring in ileocecum: A case report and literature review. Med (United States). 2017. doi:10.1097/MD.0000000000009313.

  4. Avilés A, Huerta-Guzmán J, Delgado S, Fernández A, Díaz-Maqueo JC. Improved outcome in solitary bone plasmacytomata with combined therapy. Hematol Oncol 1996;14(3):111-117. doi:10.1002/(SICI)1099- 1069(199609)14:3<111::AID-HON575>3.0.CO;2-G.

  5. González JB, González FB, Muñoz Herrera A, et al. [Extramedullary plasmacytoma of the head and neck. Report of 3 clinical cases]. An Otorrinolaringol Ibero Am 2003;30(5):501-511. http://www.ncbi.nlm.nih.gov/pubmed/ 14648930. Accessed August 4, 2019.

  6. Cheng Shen, Yasha Liang, Huan Xu, Guowei Che. Rare solitary neoplasm of the costa in an adult: A case report. World J Surg Oncol 2014. doi: 10.1186/1477-7819-12-297.

  7. Lee HY, Kim JI, Kim KN. Solitary plasmacytoma of the rib. Korean J Thorac Cardiovasc Surg 2012. doi:10.5090/ kjtcs.2012.45.4.269.

  8. Thumallapally N, Meshref A, Mousa M, Terjanian T. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer 2017;17(1):13. doi:10.1186/s12885-016-3015-5.

  9. Galieni P, Cavo M, Pulsoni A, et al. Clinical outcome of extramedullary plasmacytoma. Haematologica 2000.

  10. Kyle RA. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma: Implications for progression to overt multiple myeloma. Hematol Oncol Clin North Am 1997;11(1):71-87. doi:10.1016/S0889- 8588(05)70416-0.

  11. Burt M, Karpeh M, Ukoha O, et al. Medical tumors of the chest wall. Solitary plasmacytoma and Ewing’s sarcoma. J Thorac Cardiovasc Surg 1993;105(1):89-96. http://www. ncbi.nlm.nih.gov/pubmed/8419714. Accessed August 7, 2019.

  12. Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol 1983;1(4):255-262. doi:10.1200/JCO.1983.1.4.255.

  13. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36(3):842- 854. doi:10.1002/1097-0142(197509)36:3<842::aidcncr2820360303> 3.0.co;2-u.

  14. Rodallec MH, Feydy A, Larousserie F, et al. Diagnostic imaging of solitary tumors of the spine: what to do and say. RadioGraphics 2008;28(4):1019-1041. doi:10.1148/ rg.284075156.

  15. Moulopoulos LA, Dimopoulos MA, Weber D, Fuller L, Libshitz HI, Alexanian R. Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol 1993;11(7):1311-1315. doi:10.1200/JCO.1993.11.7.1311.

  16. Boll M, Parkins E, O’Connor SJM, Rawstron AC, Owen RG. Extramedullary plasmacytoma are characterized by a ‘myeloma- like’ immunophenotype and genotype and occult bone marrow involvement. Br J Haematol 2010;151(5):525- 527. doi:10.1111/j.1365-2141.2010.08386.x.

  17. Soutar R, Lucraft H, Jackson G, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 2004;124(6):717-726. doi:10.1111/j.1365- 2141.2004.04834.x.

  18. Ozsahin M, Tsang RW, Poortmans P, et al. Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol 2006;64(1):210-217. DOI: 10.1016/j. ijrobp.2005.06.039.

  19. Shih L, Dunn P, Leung W, Chen W, Wang P. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer 1995;71(1):128-133. doi:10.1038/bjc.1995.26.

  20. Pham A, Mahindra A. Solitary plasmacytoma: a review of diagnosis and management. Curr Hematol Malig Rep 2019;14(2):63-69. doi:10.1007/s11899-019-00499-8.

  21. Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park). 2000;14(1):101- 108, 111; discussion 111-2, 115. http://www.ncbi.nlm.nih. gov/pubmed/10680152. Accessed August 7, 2019.




2020     |     www.medigraphic.com